◆ TICKERBASE交互式视图 →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

首页全部股票 › ATR · English version

AptarGroup Inc (ATR)

来自官方财务报表的收入、利润与现金流历史。

HEALTHCARE · 华尔街(美国) · 最近更新: 2026-08-05

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures.

关键数据

查看交互式图表与完整报表 → 估值模型 (DCF) →

年度利润表

利润表TTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
总收入$3.9B$3.8B$3.6B$3.5B$3.3B$3.2B$2.9B$2.9B$2.8B$2.5B$2.3B$2.3B$2.6B$2.5B$2.3B$2.3B$2.1B$1.8B$2.1B$1.9B$1.6B
毛利$1.1B$1.1B$1.4B$1.3B$1.2B$1.2B$1.1B$1.0B$952M$865M$833M$814M$843M$811M$741M$769M$698M$616M$660M$608M$515M
毛利率%28.3%29.6%37.8%36.2%35.0%35.8%37.1%36.4%34.4%35.0%35.7%35.1%32.4%32.2%31.8%32.9%33.6%33.5%31.9%32.1%32.2%
营业利润(EBIT)$487M$512M$496M$404M$379M$347M$339M$372M$286M$322M$310M$324M$306M$285M$259M$287M$268M$206M$228M$211M$162M
营业利润率%12.4%13.6%13.9%11.6%11.4%10.8%11.6%13.0%10.3%13.0%13.3%14.0%11.8%11.3%11.1%12.3%12.9%11.2%11.0%11.1%10.1%
净利$363M$393M$375M$284M$239M$244M$214M$242M$195M$220M$206M$199M$192M$172M$163M$184M$173M$125M$153M$142M$103M
净利润率 %9.2%10.4%10.4%8.2%7.2%7.6%7.3%8.5%7.0%8.9%8.8%8.6%7.4%6.8%7.0%7.9%8.3%6.8%7.4%7.5%6.4%
EBITDA$822M$831M$777M$664M$609M$587M$556M$572M$476M$490M$470M$468M$460M$447M$397M$426M$402M$334M$371M$343M$276M
每股收益(EPS)$5.53$5.89$5.53$4.25$3.59$3.61$3.21$3.66$3.00$3.41$3.17$3.09$2.85$2.52$2.38$2.65$2.48$1.79$2.18$1.98$1.43
已发行股数 (M)65M67M68M67M67M68M67M66M65M65M65M64M67M68M68M69M70M70M71M72M72M

来源:公司公开报告(SEC)。在依赖任何数字前请核对 SEC EDGAR。

资产负债表、现金流、季度数据与完整财务比率见 ATR 交互式查看器。 /companies/us/ATR

类似公司

本网站信息仅用于教育与参考,不构成投资建议。不发布目标价或买卖建议。

English version →全部股票

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.